250,000 Kenyans screened for diabetes, hypertension in Boehringer programme
Boehringer Ingelheim says it has screened more than 250,000 Kenyans and placed over 20,000 on treatment for diabetes and hypertension since 2022 through its Access to Healthcare programme targeting underserved communities.
Full story
Read the full story at Capital FM Kenya ↗
Continue reading this story on Capital FM Kenya, the publisher that reported it.
AI tools
Written by AI from the article text. It can make mistakes; check the original story.